Viome

Bellevue, Washington, USA · ≈96 employees · viome.com

Viome is a systems biology company founded in 2016, dedicated to analyzing individual biology at a molecular level. The company aims to make illness optional by predicting and preventing chronic diseases such as cancer, diabetes, and obesity. Viome utilizes advanced RNA sequencing technology to understand the active functions of microbes in the body, combining this with artificial intelligence to provide personalized health insights. Viome offers a range of personalized health solutions, including the Full Body Intelligence™ Test, which analyzes cellular and microbiome activity. Based on these insights, Viome provides customized food recommendations and precision supplements tailored to individual health needs. Their ViOS platform digitizes biological samples for in-depth analysis, while Viome Pro serves modern medical practices with precision health data. The company also conducts clinical studies to further explore health and aging, empowering individuals to take control of their wellness.

Health, Wellness & Fitness

Also: bioinformatics · machine learning · big data · software engineering · nutrition · health · gut biome · health & wellness · information technology · deep information technology · wellness & fitness services · healthspan

Funding0

Every round, secondary, debt facility or acquisition involving Viome that Lounge tracks, newest first.

No rounds recorded yet.

Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.

See plans →Log in

Viome

Funding0

Key numbers

Also on Lounge